CWI1-2 HCL is an effective IGF2BP2 inhibitor, which can induce apoptosis and differentiation by binding IGF2BP2 and inhibiting its interaction with M6A-modified target transcription, and has therapeutic effects on leukemia.
Molecular Weight:
556.23
Purity:
99.18%
CAS Number:
[2408590-37-2]
Formula:
C22H18Cl4N6O3
Target:
Apoptosis
T67930L
* VAT and and shipping costs not included. Errors and price changes excepted